Literature DB >> 12202564

Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae.

Michael R Jacobs1, Saralee Bajaksouzian, Anne Windau, Peter C Appelbaum, Gengrong Lin, David Felmingham, Christine Dencer, Laura Koeth, Mendel E Singer, Caryn E Good.   

Abstract

As considerable variation in the antimicrobial susceptibility of Haemophilus influenzae has been reported, the effects of various test media on the susceptibility of H. influenzae were studied. MICs were determined by three laboratories for 21 antimicrobial agents against a panel of 100 selected isolates. Testing was performed using a reference NCCLS frozen broth microdilution method with Haemophilus test medium (HTM) broth and dried commercial MIC trays rehydrated with the following media: in-house and commercially prepared HTM broth, Mueller-Hinton broth with 2% lysed horse blood and NAD, IsoSensitest broth with 2% lysed horse blood and NAD, and IsoSensitest broth-based HTM. Overall, all results were very reproducible, with the MIC at which 50% of the isolates tested are inhibited (MIC(50)), MIC(90), and geometric mean MIC being within one doubling dilution by all six methods and at all three testing centers for 15 of the 21 agents tested. Interlaboratory differences were more marked than intralaboratory differences or differences among media. Cefprozil, cefaclor, and trimethoprim-sulfamethoxazole results differed the most, while results for ampicillin, amoxicillin-clavulanic acid, cefdinir, cefixime, ceftriaxone, and clarithromycin were the most reproducible. However, these variations in results caused considerable differences in susceptibility rates for agents for which NCCLS susceptible breakpoints were close to the geometric mean MIC, particularly for cefaclor and cefprozil. This was much less of a problem when pharmacokinetic-pharmacodynamic breakpoints were used. Reproducible susceptibility results were obtained for a wide range of agents against H. influenzae in three laboratories using a variety of media that support the growth of this fastidious species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202564      PMCID: PMC130805          DOI: 10.1128/JCM.40.9.3269-3276.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Assessing the quality of the Alexander Project.

Authors:  M R Jacobs
Journal:  J Chemother       Date:  1999-02       Impact factor: 1.714

Review 2.  Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae.

Authors:  J H Jorgensen
Journal:  Clin Infect Dis       Date:  1992-05       Impact factor: 9.079

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Osmotically stable L forms of Haemophilus influenzae and their significance in testing sensitivity to penicillins.

Authors:  J R May; D E Roberts; A Ingold; S V Want
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

5.  Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae.

Authors:  R B Sykes; A Griffiths; D M Ryan
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

6.  Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

7.  Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.

Authors:  J H Jorgensen; G V Doern; L A Maher; A W Howell; J S Redding
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

8.  Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics.

Authors:  V P Syriopoulou; D W Scheifele; C M Sack; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

9.  Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.

Authors:  R R Bulger; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

10.  National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.

Authors:  G V Doern; J H Jorgensen; C Thornsberry; D A Preston; T Tubert; J S Redding; L A Maher
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

View more
  8 in total

1.  Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.

Authors:  Aneliya Milanova Haritova; Nikolina Velizarova Rusenova; Parvan Rusenov Parvanov; Lubomir Dimitrov Lashev; Johanna Fink-Gremmels
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes.

Authors:  Melvin P Weinstein; James S Lewis
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

3.  Analysis of MIC and Disk Diffusion Testing Variables for Gepotidacin and Comparator Agents against Select Bacterial Pathogens.

Authors:  L M Koeth; J M DiFranco-Fisher; N E Scangarella-Oman; L A Miller
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

Review 4.  Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Authors:  Jack B Anon; Michael R Jacobs; Michael D Poole; Paul G Ambrose; Mark S Benninger; James A Hadley; William A Craig
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

5.  Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.

Authors:  L M Koeth; E Matuschek; G Kahlmeter; G Stone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-30       Impact factor: 3.267

Review 6.  Antimicrobial resistance in Haemophilus influenzae.

Authors:  Stephen Tristram; Michael R Jacobs; Peter C Appelbaum
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

Review 7.  Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.

Authors:  Caroline M Perry; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong.

Authors:  Pak-Leung Ho; Kin Hung Chow; Gannon C Mak; Kenneth W Tsang; Yu Lung Lau; Alex Y Ho; Eileen L Lai; Susan S Chiu
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.